Eli Lilly: BofA Global Research cuts price objective to $1,341 from $1,344
LLY•BofA Global Research cut its price objective for Eli Lilly to $1,341 from $1,344.
Related News
Nasdaq pauses trading in VIVK for volatility at 9:51 a.m.
VIVK•
Nasdaq trade halt continues; reason not available at 10:10 a.m.
UCFI•
Delta Air cuts profit forecast as $6 billion fuel-cost surge outstrips fare gains
DAL•
BofA Global Research cuts BellRing Brands price objective to $9 from $10
BRBR•
BlackRock Financial Management discloses net short position in Aéroports de Paris
BLK•